US Broker Ratings

Align Technology, Inc. (ALGN) Stock Analysis: Understanding the 34.86% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the medical instruments and supplies industry, has long been at the forefront of dental innovation with its Invisalign..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Healthcare Giant with a 4.3% Upside

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to be a compelling choice for investors seeking exposure to the drug manufacturing industry. With..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 19.56% Potential Upside

For investors eyeing the healthcare sector, DaVita Inc. (NYSE: DVA) presents an intriguing opportunity, particularly given its potential upside of 19.56% based on current analyst evaluations...

Cencora, Inc. (COR) Stock Analysis: A Strong Performer with a Robust 116.71% ROE

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically in medical distribution. With a rich history..

Haleon plc (HLN) Stock Analysis: Evaluating a 22.78% Upside Potential Amid Global Consumer Healthcare Demand

Haleon plc (HLN) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in Weybridge,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Navigating Potential Upside with Robust Dividends

Gilead Sciences, Inc. (NASDAQ: GILD), a biopharmaceutical giant known for its innovative treatments in areas of unmet medical need, stands as a compelling consideration for investors..

Hologic, Inc. (HOLX) Stock Analysis: Exploring the 4.40% Potential Upside

As the healthcare sector continues to evolve, Hologic, Inc. (NASDAQ: HOLX) stands out as a key player in the medical instruments and supplies industry. With a..

BioNTech SE (BNTX) Stock Analysis: Exploring a 28.63% Upside Amidst Strong Buy Ratings

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been a focal point for investors seeking to navigate the complexities of the healthcare..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 16.74% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the healthcare sector, is making waves in the medical devices industry with its innovative cardiovascular treatments. Headquartered in..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating a 13.73% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, offers a compelling investment opportunity with its focus on addressing unmet medical needs in..

Natera, Inc. (NTRA) Stock Analysis: A Diagnostic Powerhouse with Promising Upside

Natera, Inc. (NASDAQ: NTRA), a leader in the diagnostics and research industry, continues to make waves in the healthcare sector with its innovative molecular testing services...

McKesson Corporation (MCK) Stock Analysis: Unveiling Growth Potential with a 6.45% Upside

McKesson Corporation (NYSE: MCK) continues to capture the attention of investors as a prominent player in the healthcare sector. With a sprawling market cap of $97.77..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth Amidst a Potential -5.64% Downside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a formidable player in the biotechnology sector, continues to attract investor attention with its pioneering work in RNA interference therapeutics. With..

The Cooper Companies, Inc. (COO) Stock Analysis: Eyeing a 15% Upside in Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector specializing in medical instruments and supplies, is capturing the attention of investors with..

Agilent Technologies, Inc. (A) Stock Analysis: Understanding the 4.68% Upside Potential

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector with a focus on diagnostics and research, is capturing investor attention with its promising..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating a 10.14% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a cornerstone in the medical instruments and supplies industry, is capturing investor attention with its robust market presence and a..

DexCom, Inc. (DXCM) Stock Analysis: Discovering a 48.59% Potential Upside in the Healthcare Sector

DexCom, Inc. (DXCM), a leading player in the healthcare sector specializing in medical devices, is capturing significant attention from investors due to its innovative solutions in..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential Amidst Strong Revenue Growth and Dividend Yield

Novartis AG (NYSE: NVS), a key player in the healthcare sector, stands out in the Drug Manufacturers industry with a substantial market capitalization of $254.76 billion...

Sanofi (SNY) Investor Outlook: Strong Buy Ratings and a 21% Upside Potential

Sanofi (SNY), a leading player in the healthcare sector and general drug manufacturing industry, has been attracting considerable attention from investors. With its headquarters in Paris,..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Biotech Giant with 25% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a formidable player in the biotechnology sector, presents an attractive investment opportunity with significant growth prospects. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds